DexCom Stock Hits New 52-Week Low (DXCM)

NEW YORK ( TheStreet) -- DexCom (Nasdaq: DXCM) hit a new 52-week low Monday as it is currently trading at $6.87, below its previous 52-week low of $6.90 with 50,212 shares traded as of 10:09 a.m. ET. Average volume has been 658,800 shares over the past 30 days.

DexCom has a market cap of $472.6 million and is part of the health care sector and health services industry. Shares are down 48% year to date as of the close of trading on Friday.

DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.

TheStreet Ratings rates DexCom as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full DexCom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Stocks Slide on Renewed Trade War Concerns

Stocks Slide on Renewed Trade War Concerns

Emerging Markets Get Pounded by Global Trade Concerns

Emerging Markets Get Pounded by Global Trade Concerns

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Stocks Dive Globally as U.S.-China Trade War Intensifies

Stocks Dive Globally as U.S.-China Trade War Intensifies